# Compass Therapeutics, Inc.: Form 8-K, filed Aug 1, 2022

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2022-08-01
- Accepted by EDGAR: Aug 1, 2022, 08:20 ET
- Period: 2022-07-22
- Accession: 0001193125-22-207806
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000119312522207806/d379291d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000119312522207806/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000119312522207806/d379291d8k.htm

Filed Aug 1, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-207806. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
